BamSEC and AlphaSense Join Forces
Learn More

Milestone Pharmaceuticals Inc.

NASDAQ: MIST    
Share price (1/6/25): $2.19    
Market cap (1/6/25): $117 million

Articles of Incorporation Filter

EX-3.2
from 8-K 31 pages By-Law 2019-1 a By-Law Relating Generally to the Transaction of the Business and Affairs of Milestone Pharmaceuticals Inc. Milestone Pharmaceutiques Inc
12/34/56
EX-3.1
from 8-K 6 pages Unofficial Translation Re-509 (2012-07) Page 2 if Insufficient Space Provided Above, Attach a Schedule, Indicate the Section and Number the Pages, if Necessary. 5.restrictions on Business Activities, if Applicable None 6.other Provisions, if Applicable See Attached Schedule 2. 7.date and Time to Be Assigned to the Certificate, if Applicable Date Hour 8.signature Name of Authorized Director or Officersignature of Authorized Director or Officer
12/34/56
EX-3.2
from S-1/A 6 pages Unofficial Translation Re-509 (2012-07) Page 2 if Insufficient Space Provided Above, Attach a Schedule, Indicate the Section and Number the Pages, if Necessary. 5.restrictions on Business Activities, if Applicable None 6.other Provisions, if Applicable See Attached Schedule 2. 7.date and Time to Be Assigned to the Certificate, if Applicable Date Hour 8.signature Name of Authorized Director or Officersignature of Authorized Director or Officer
12/34/56
EX-3.4
from S-1 29 pages By-Law 2019-1 a By-Law Relating Generally to the Transaction of the Business and Affairs of Milestone Pharmaceuticals Inc. Milestone Pharmaceutiques Inc
12/34/56
EX-3.3
from S-1 25 pages By-Law No. 2017-1 a By-Law Relating Generally to the Transaction of the Business and Affairs of Milestone Pharmaceuticals Inc. Milestone Pharmaceutiques Inc
12/34/56
EX-3.1
from S-1 27 pages Articles of Milestone Pharmaceutiques Inc. Milestone Pharmaceuticals Inc. (The “Corporation”) Schedule 1 Schedule 1a Description of Share Capital
12/34/56
EX-3.3
from DRS 25 pages By-Law No. 2017-1 a By-Law Relating Generally to the Transaction of the Business and Affairs of Milestone Pharmaceuticals Inc. Milestone Pharmaceutiques Inc
12/34/56
EX-3.1
from DRS 27 pages Articles of Milestone Pharmaceutiques Inc. Milestone Pharmaceuticals Inc. (The “Corporation”) Schedule 1 Schedule 1a Description of Share Capital
12/34/56